- Home
- ABEO vs MQT Comparison
ABEO vs MQT Comparison
Compare ABEO & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- MQT
- Stock Information
- Founded
- ABEO N/A
- MQT 1992
- Country
- ABEO United States
- MQT United States
- Employees
- ABEO N/A
- MQT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- MQT Investment Bankers/Brokers/Service
- Sector
- ABEO Health Care
- MQT Finance
- Exchange
- ABEO Nasdaq
- MQT Nasdaq
- Market Cap
- ABEO 277.6M
- MQT 230.6M
- IPO Year
- ABEO 1980
- MQT N/A
- Fundamental
- Price
- ABEO $5.86
- MQT $10.33
- Analyst Decision
- ABEO Strong Buy
- MQT
- Analyst Count
- ABEO 3
- MQT 0
- Target Price
- ABEO $18.00
- MQT N/A
- AVG Volume (30 Days)
- ABEO 292.3K
- MQT 52.5K
- Earning Date
- ABEO 11-14-2024
- MQT 01-01-0001
- Dividend Yield
- ABEO N/A
- MQT 4.60%
- EPS Growth
- ABEO N/A
- MQT N/A
- EPS
- ABEO N/A
- MQT N/A
- Revenue
- ABEO N/A
- MQT N/A
- Revenue This Year
- ABEO N/A
- MQT N/A
- Revenue Next Year
- ABEO $7,097.06
- MQT N/A
- P/E Ratio
- ABEO N/A
- MQT N/A
- Revenue Growth
- ABEO 147.52
- MQT N/A
- 52 Week Low
- ABEO $3.05
- MQT $8.59
- 52 Week High
- ABEO $9.01
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- ABEO 38.62
- MQT 40.25
- Support Level
- ABEO $5.95
- MQT $10.36
- Resistance Level
- ABEO $6.78
- MQT $10.62
- Average True Range (ATR)
- ABEO 0.32
- MQT 0.11
- MACD
- ABEO -0.07
- MQT 0.01
- Stochastic Oscillator
- ABEO 7.07
- MQT 23.68
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.